TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2019

Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma.

Neeraj Y Saini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.